Concepedia

Publication | Open Access

Oral desensitization therapy for peanut allergy induces dynamic changes in peanut‐specific immune responses

43

Citations

47

References

2022

Year

Abstract

Oral desensitization therapy with AR101 leads to decreased basophil sensitivity to peanut and reshapes peanut-reactive T effector cell responses supporting its potential as an immunomodulatory therapy.

References

YearCitations

Page 1